Sorry, you need to enable JavaScript to visit this website.
hamburger overlay

Proud to partner with JDRF


Did you know that we have collaborated with patient organisation JDRF (the Juvenile Diabetes Research Foundation) for over ten years? This article shares the ways in which we work together and some of the things we’ve collectively achieved.

In the UK, we are proud to be the ongoing headline sponsor of the JDRF series of Discovery Day meetings. The Discovery Days are free events and a great opportunity to meet others with type 1, find out about the latest research progress, and hear inspirational talks from a range of speakers. They help to bring together the type 1 diabetes community and provide information, inspiration and a support network to those living with type 1 diabetes.

Lucy Mason Pearson, JDRF’s Corporate Partnerships Manager, shares her thoughts on this collaboration: “The multi-year sponsorship from Roche Diabetes Care enables JDRF to plan and improve the Discovery Day programme. Their involvement in the programme has enabled us to reach a wider community including healthcare.

“Involvement with the Discovery Day programme enables Roche Diabetes Care staff to liaise with the type 1 community which provides them with a deeper knowledge of the type 1 diabetes lived experience.”

Owing to the COVID-19 crisis, many 2020 events had to be cancelled or postponed. To help with the continuation of these events we supported the transition of these to virtual meetings. The virtual events are proving popular, face-to-face events normally attract between 70-110 people but the virtual events, where location is no barrier, are attracting audiences of around 230 people at each.

You can find out more about the Discovery Days here.

In 2019, we also embarked on a ‘Pathway to Choice’ initiative with JDRF, to help build awareness of and access to type 1 diabetes technology choices.

Alongside other industry partners, we collectively wanted to understand the motivations and barriers people with type 1 diabetes face in making treatment choices so a piece of market research was commissioned.  The findings of the research were published as a report that will enable us all to explore the types of support and interventions we can develop to help people living with type 1 diabetes choose the best possible treatments. Working together on this project allows for a far deeper understanding of barriers to choice with technology, demonstrating yet again that ‘United, we Manage diabetes better’.

You can access the ‘Pathway to Choice’ report here.

25 September 2020